Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: A cohort study
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Individuals with obesity do not represent a homogeneous group in terms of cardiometabolic risk. Using 3 nationally representative British birth cohorts, we investigated whether the duration of obesity was related to heterogeneity in cardiometabolic risk. Methods and findings: We used harmonised body mass index (BMI) and cardiometabolic disease risk factor data from 20,746 participants (49.1% male and 97.2% white British) enrolled in 3 British birth cohort studies: the 1946 National Survey of Health and Development (NSHD), the 1958 National Child Development Study (NCDS), and the 1970 British Cohort Study (BCS70). Within each cohort, individual life course BMI trajectories were created between 10 and 40 years of age, and from these, age of obesity onset, duration spent obese (range 0 to 30 years), and cumulative obesity severity were derived. Obesity duration was examined in relation to a number of cardiometabolic disease risk factors collected in mid-adulthood: systolic (SBP) and diastolic blood pressure (DBP), high-density-lipoprotein cholesterol (HDL-C), and glycated haemoglobin (HbA1c). A greater obesity duration was associated with worse values for all cardiometabolic disease risk factors. The strongest association with obesity duration was for HbA1c: HbA1c levels in those with obesity for <5 years were relatively higher by 5% (95% CI: 4, 6), compared with never obese, increasing to 20% (95% CI: 17, 23) higher in those with obesity for 20 to 30 years. When adjustment was made for obesity severity, the association with obesity duration was largely attenuated for SBP, DBP, and HDL-C. For HbA1c, however, the association with obesity duration persisted, independent of obesity severity. Due to pooling of 3 cohorts and thus the availability of only a limited number harmonised variables across cohorts, our models included adjustment for only a small number of potential confounding variables, meaning there is a possibility of residual confounding. Conclusions: Given that the obesity epidemic is characterised by a much earlier onset of obesity and consequently a greater lifetime exposure, our findings suggest that health policy recommendations aimed at preventing early obesity onset, and therefore reducing lifetime exposure, may help reduce the risk of diabetes, independently of obesity severity. However, to test the robustness of our observed associations, triangulation of evidence from different epidemiological approaches (e.g., mendelian randomization and negative control studies) should be obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792 · cited 2×
“Abbreviations: AUC, area under the curve; BCS70, 1970 British Cohort Study; BMI, body mass index; BIC, Bayesian information criterion; BP, blood pressure; DBP, diastolic blood pressure; FMI, fraction missing information; HbA1c, glycated haemoglobin; HDL-C, high-density-lipoprotein cholesterol; IOTF, International Obes…”
MethodHealth effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Self-citationDiagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690 · cited 1×
“This state leads to peripheral and hepatic insulin resistance [47,48], resulting in a compensatory insulin hypersecretion by the pancreatic β-cells in order to preserve normoglycemia [49].”
BackgroundChildhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
Juonala, M., Magnussen, C. G., Berenson, G. S., Venn, A., Burns, T. L., Sabin, M. A., Srinivasan, S. R., Daniels, S. R., Davis, P. H., Chen, W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010112 · Cited by 1,665
Multiple Imputation by Chained Equations (MICE): Implementation in Stata
Royston, P., & White, I. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i04 · Cited by 1,248
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232
Prevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917
Sex differences in metabolic homeostasis, diabetes, and obesity
Mauvais-Jarvis, F. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0033-y · Cited by 626
Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee, R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00336 · Cited by 609 · cited 1×
“The constants were +10 mmHg and +5 mmHg for SBP and DBP, respectively, −5% for HDL-C and +1% (absolute) for HbA1c, obtained from meta-analyses of the effect of blood pressure lowering [35], lipid-regulating [36–38], and diabetes [39] medications on the respective cardiometabolic risk factors.”
MethodCohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development)
Wadsworth, M., Kuh, D., Richards, M., & Hardy, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi201 · Cited by 515
Self-citationCohort Profile: 1970 British Birth Cohort (BCS70)
Elliott, J., & Shepherd, P. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl174 · Cited by 488
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes
Bjerregaard, L. G., Jensen, B. W., Ängquist, L., Osler, M., Sørensen, T. I. A., & Baker, J. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713231 · Cited by 392
Costa, J., Borges, M., David, C., & Carneiro, A. V. (2006) · BMJ · doi:10.1136/bmj.38793.468449.ae · Cited by 340
Prevalence of the Metabolic Syndrome Among Omani Adults
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1781 · Cited by 267
Adolescent Obesity, Change in Weight Status, and Hypertension: Racial/Ethnic Variations
Suglia, S. F., Clark, C. J., & Gary-Webb, T. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00214 · Cited by 55
Cited by
A review of current guidelines for the treatment of obesity
(2022) · The American Journal of Managed Care · doi:10.37765/ajmc.2022.89292 · Cited by 207
Wang, J., Wu, M., Wu, S., & Tian, Y. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13820 · Cited by 49
Wang, J., Wang, F., Chen, H., Liu, L., Zhang, S., Luo, W., Wang, G., & Hu, X. (2022) · Nutrients · doi:10.3390/nu14112315 · Cited by 17
Ma, Y., Sun, L., & Mu, Z. (2024) · International Journal of Obesity · doi:10.1038/s41366-023-01416-z · Cited by 12
Zhou, Y., Hou, Y., Xiang, J., Dai, H., Li, M., Wang, T., Wang, S., Lin, H., Lu, J., Xu, Y., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00629-1 · Cited by 6
Metadata
- Authors
- Norris, T., Cole, T. J., Bann, D., Hamer, M., Hardy, R., Li, L., Ong, K. K., Ploubidis, G. B., Viner, R., & Johnson, W.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-12-08
- Volume
- 17
- Issue
- 12
- Pages
- e1003387
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W3113088377
- Cited by
- 85
- References
- 17
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.